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Abstract 
Hyperglycemia is associated with generation of reactive oxygen species (ROS), and this action may contribute to 
accelerated atherogenesis. We tested the hypothesis that hyperglycemia produces alterations in left anterior 
descending coronary artery (LAD) wall shear stress concomitant with endothelial dysfunction and ROS 
production in dogs (n = 12) instrumented for measurement of LAD blood flow, velocity, and diameter. Dogs were 
randomly assigned to receive vehicle (0.9% saline) or the superoxide dismutase mimetic 4- hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxyl (tempol) and were administered intravenous infusions of d-glucose to achieve 
target blood glucose concentrations of 350 and 600 mg/dl (moderate and severe hyperglycemia, respectively). 
Endothelial function and ROS generation were assessed by coronary blood flow responses to acetylcholine (10, 
30, and 100 ng/kg) and dihydroethidium fluorescence of myocardial biopsies, respectively. Indexes of wall shear 
stress were calculated with conventional fluid dynamics theory. Hyperglycemia produced dose-related 
endothelial dysfunction, increases in ROS production, and reductions in oscillatory shear stress that were 
normalized by tempol. The results suggest a direct association between hyperglycemia-induced ROS production, 
endothelial dysfunction, and decreases in oscillatory shear stress in vivo. 
reactive oxygen species (ROS) have been implicated in the pathogenesis of cardiovascular disease during 
diabetes mellitus and hyperglycemia. Several potential mechanisms have been identified that may account for 
increases in ROS generation during hyperglycemia including glucose autooxidation (2), mitochondrial superoxide 
anion overproduction by the electron transport chain (32), depletion of tetrahydrobiopterin (34), and synthesis 
of advanced glycation end-products (36). Hyperglycemia inhibits endothelium-dependent coronary vasodilation 
through oxidant-sensitive mechanisms (20, 21, 38). A disproportionate increase in superoxide anion compared 
with nitric oxide (NO) concentrations occurs during hyperglycemia that may account for endothelial dysfunction 
by altering the balance of oxidant stress (2, 5, 6), and this effect is attenuated by free radical scavengers that 
indirectly increase the availability of NO (2,29, 35, 38). 
Hyperglycemia has also been shown to adversely alter vascular fluid dynamics. An inverse relation between 
fasting blood glucose concentrations and wall shear stress has been observed in patients with diabetes 
compared with age-matched controls (15, 16), and endothelium-derived relaxing factors including NO are 
modulated by wall shear stress in a frequency- and amplitude-dependent manner (11,12). Regions of the arterial 
vasculature that are chronically exposed to low-magnitude and oscillatory wall shear stress are known to be 
more susceptible to the development of atherogenesis (9,23). Collectively, these studies suggest that 
hyperglycemia-induced ROS production may alter endothelial function and account for reductions in indexes of 
wall shear stress. To date, no studies have examined the direct effects of hyperglycemia on coronary wall shear 
stress, ROS production, and endothelial function simultaneously in vivo. We tested the hypothesis that 
hyperglycemia-induced ROS production is linked to coronary endothelial dysfunction and decreases in wall shear 
stress in dogs. 
MATERIALS AND METHODS 
All experimental procedures and protocols used in this investigation were reviewed and approved by the 
Institutional Animal Care and Use Committee of the Medical College of Wisconsin. All conformed to the Guiding 
Principles in the Care and Use of Animals of the American Physiological Society and the Guide for the Care and 
Use of Laboratory Animals of the National Institutes of Health (7th ed., Washington, DC: National Academy 
Press, 1996). 
Surgical preparation. 
Implantation of instruments was described previously (24). Adult mongrel dogs of either sex and weighing 
between 18 and 24 kg were fasted overnight and anesthetized with barbital (200 mg/kg) and pentobarbital 
sodium (15 mg/kg). After endotracheal intubation, dogs were ventilated using positive pressure with an air-
oxygen mixture (FiO2 = 0.28–0.30). Arterial blood gas tensions and acid-base status were maintained within 
physiological limits by adjusting tidal volume and respiratory rate. Fluid-filled catheters were inserted into the 
right femoral vein and artery for fluid administration and arterial blood gas sampling, respectively. A 
thoracotomy was performed in the fifth intercostal space, the lungs were gently retracted, and the pericardium 
was incised. A dual micromanometer-tipped catheter was inserted into the left ventricle (LV) and ascending 
aorta for measurement of LV and arterial pressures, respectively, and the maximum rate of increase of LV 
pressure (dP/dtmax). A 1.5- to 2-cm segment proximal to the first diagonal branch of the left anterior descending 
coronary artery (LAD) was isolated, and 2.5-mm ultrasonic segment length (Triton, San Diego, CA) and transit 
time blood flow (Transonic Systems, Ithaca, New York) transducers were placed around the vessel for 
measurement of external diameter and regional blood flow (Fig.1A). A precalibrated 20-MHz pulsed Doppler 
flow probe was placed around the LAD just distal to the first diagonal branch to measure local blood flow 
velocity at the myocardial and pericardial luminal surfaces (Fig. 1B). A fluid-filled catheter was inserted into the 
left atrium through the atrial appendage for administration of acetylcholine. Fluid deficits were replaced before 
experimentation with 500 ml of 0.9% saline, which was continued at 3 ml · kg−1 · h−1for the duration of each 
experiment. Hemodynamic data were continuously monitored on a polygraph and simultaneously digitized (364 
Hz) with a computer interfaced with an analog-to-digital converter. 
 
Fig. 1.A: schematic diagram of the instrumentation used to measure left anterior descending coronary artery 
(LAD) blood flow velocity and LAD external diameter. B: location of the myocardial and pericardial luminal 
surfaces. 
 
Experimental protocol. 
Baseline systemic and coronary hemodynamics were recorded 90 min after instrumentation was completed. 
Dogs were randomly assigned to receive 0.9% saline (vehicle; n = 6) or the superoxide dismutase mimetic 4-
hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol; 100 mg/kg in 0.9% saline over 15 min; Sigma, St. Louis, 
MO;n = 6). Hemodynamics were acquired under steady-state conditions after vehicle or tempol pretreatment 
and during acetylcholine infusions (10, 30, and 100 ng/kg) (27). Tissue samples were removed with a biopsy 
needle (Bard, Billerica, MA) during each intervention from the left circumflex coronary artery perfusion territory 
for measurement of ROS. Blood glucose concentrations and arterial blood gas tensions were determined during 
each intervention. After the administration of vehicle or tempol and acetylcholine, blood glucose concentrations 
were sequentially increased to 350 and 600 mg/dl (moderate and severe hyperglycemia, respectively) with an 
intravenous infusion of d-glucose. Target concentrations of blood glucose were selected on the basis of a 
previous investigation demonstrating the ability of hyperglycemia to cause dose-dependent reductions in 
coronary collateral blood flow in dogs (19). Each target blood glucose concentration was maintained for 90 min, 
and systemic and coronary hemodynamics before and during administration of acetylcholine were recorded. 
Myocardial biopsies were also obtained during each intervention in the presence or absence of hyperglycemia. 
Detection of ROS. 
Production of ROS was quantified during each intervention from myocardial biopsy samples with the fluorescent 
dye dihydroethidium. Dihydroethidium is oxidized by intracellular ROS to produce fluorescent ethidium that is 
subsequently intercalated in DNA, further amplifying its fluorescence (4). In cell-free assays, the addition of 
hydrogen peroxide to dihydroethidium does not increase ethidium fluorescence (28). Thus an increase in 
dihydroethidium oxidation and the subsequent increase in fluorescence are highly suggestive of superoxide 
generation. Myocardial biopsy samples were incubated in PBS at 37°C overnight, washed with PBS, and 
incubated in 5 μM dihydroethidium for 30 min. Images were obtained from each intervention with a laser 
fluorescence imaging system (Odyssey Laser Scanning Confocal Microscopic Imaging System; Noran Instruments, 
Madison, WI) mounted on a microscope (Optiphot; Nikon, Tokyo, Japan) and stored for off-line analysis on a 
computer workstation equipped with image-analysis software (MetaMorph; Universal Imaging, Downingtown, 
PA). Excitation was produced with a krypton-argon laser at a wavelength of 488 nm and emitted fluorescence 
was measured at 610 nm. The pixel intensity of each myocyte nucleus was determined after compensating for 
background fluorescence by subtraction of an area without cells or minimal cytosolic fluorescence. For each 
experiment, 7 images were obtained at each intervention and the intensity of 10 myocardial nuclei were 
analyzed in each image. 
Determination of endothelial function. 
Endothelial function was quantified by the coronary vasodilator response to acetylcholine (27). Acetylcholine 
infusions were administered into the left atrial appendage during each intervention at a rate of 0.5 μl/s for 4 s. 
The rate and duration of acetylcholine administration were selected to achieve increases in coronary blood flow 
similar to those described previously (27). Hemodynamics were allowed to return to steady-state conditions 
before subsequent doses of acetylcholine were administered. 
Ensemble averaging of hemodynamics. 
LV and aortic blood pressure, LAD blood flow and velocity, and LAD external diameter waveforms were digitally 
recorded for each intervention. A representative time series of one cardiac cycle for each waveform was 
generated with a custom-designed MATLAB (MathWorks, Natick, MA) program that identified peak LV pressure 
to temporally align the variables in each digitized waveform, segment each variable time series, and ensemble-
average the segments. 
Determination of internal LAD diameter. 
The LAD coronary artery was excised, and the length (L) of the vascular segment was determined in situ at the 
completion of each experiment. The internal LAD radius (ri) was determined with the equation ri = 
(r2oo2 −V/Lπ)½, wherer2oo2 is the external LAD radius andV is the ratio of the excised vessel weight to density 
(assumed as 1.06 g/ml) (31). 
Determination of local coronary blood flow velocity. 
Local blood flow velocity at the pericardial and myocardial luminal surfaces (Fig. 1B) of the LAD segment was 
determined using pulsed Doppler techniques (1, 24, 26). Briefly, a piezoelectric crystal with a stationary 
predetermined insonation angle that is fixed within a Doppler probe is deformed, emitting an ultrasonic pulse 
that propagates through the vessel wall to a specified depth. The pulse is then reflected back to the crystal and 
interpreted as a frequency shift. To ensure repeatability between interventions and experiments, Doppler pulse 
penetration depth had been previously correlated to values on a digital voltmeter. Digitized sample volumes 
(∼0.23 mm3) were obtained at 12 axial depths across the vessel and converted to blood flow velocity by 
determination of insonation angle as previously described (1). Velocity waveforms at each axial depth were 
ensemble-averaged and spatially aligned to reconstruct velocity profiles for each intervention. Least-squares 
interpolation was then performed to acquire near-wall velocity assuming no slip at the vessel wall. 
Determination of blood viscosity. 
Blood samples (3 ml each) were withdrawn from the femoral artery catheter during each intervention for 
measurement of blood viscosity. Samples were placed in EDTA-containing vials and agitated continuously to 
maintain uniform cellular composition. Blood viscosity was measured in duplicate at 37°C for five different shear 
rates (375, 187.5, 75, 56.25, and 30 s−1) with a cone and plate viscometer (DVII+; Brookfield Engineering Labs, 
Stoughton, MA). Blood viscosity was then plotted against shear rate, and equations describing a three-constant 
exponential decay relationship of the curve were obtained for each intervention by using a Marquardt-
Levenberg algorithm with commercially available software (Sigma Plot 2000; SPSS, Chicago, IL). 
Determination of global and local indexes of shear stress. 
Shear rate was determined by two methods. Global shear rate (γ) within the LAD vascular segment bounded by 
the surgical instrumentation was estimated from Poiseuille's law using the equation γ = 4Q˙πr3ii3, whereQ˙ is the 
rate of coronary blood flow. Local wall shear rate was calculated from blood velocity measurements at the LAD 
coronary artery walls nearest to the pericardial and myocardial luminal surfaces (Fig. 1B) by a finite difference 
method using the differential equation γu = −∂u/∂r, where ∂u/∂r is the partial derivative of the velocity 
magnitude with respect to the radial vessel position (r) (13). Global (τ) and local (τu) shear stress for each time 
point in the cardiac cycle were calculated as the product of the measured in vivo viscosity and the respective 
global or local shear rate. Oscillatory shear stress (τos) was determined as the magnitude of the shear stress 
waveform (Fig. 2). The rate of oscillatory shear stress (τ˙os) was also calculated as the product of τos and heart 
rate. 
 
Fig. 2.Ensemble-averaged wall shear stress waveform obtained from a typical experiment during baseline 
conditions. Oscillatory wall shear stress (τos) was determined as the magnitude of the wall shear stress waveform 
as depicted. 
 
Statistical analysis. 
Statistical analysis of data within and between groups was performed with multiple ANOVA for repeated 
measures, followed by Student-Newman-Keuls test. A P value <0.05 was considered to be statistically significant. 
All data are expressed as means ± SE. 
RESULTS 
Fourteen dogs were instrumented to obtain twelve successful experiments. Two dogs were excluded from the 
control group because of technical problems with instrumentation. ROS measurements for one dog in the 
tempol group were excluded because of inadequate dihydroethidium staining. 
The hemodynamic effects of tempol and hyperglycemia are summarized in Table 1. No differences in baseline 
hemodynamics were observed between vehicle- and tempol-pretreated dogs. There was a small but significant 
increase in blood glucose concentration before the administration of d-glucose in tempol-treated dogs. 
Hyperglycemia significantly (P < 0.05) increased LV dP/dtmax in dogs receiving vehicle, but heart rate, LV and 
aortic pressures, coronary blood flow, and LAD diameter were unchanged. In contrast, heart rate and mean 
arterial and LV systolic pressures were decreased during hyperglycemia in dogs pretreated with tempol. 
Hyperglycemia attenuated increases in coronary blood flow in response to acetylcholine in dogs receiving 
vehicle (e.g., 242 ± 30% at baseline compared with 190 ± 27% increase from control during moderate 
hyperglycemia; Fig.3). Pretreatment with tempol completely abolished this hyperglycemia-induced attenuation 
of coronary vasodilation in response to acetylcholine. Infusions ofd-glucose produced dose-related increases in 
fluorescence intensity in dogs receiving vehicle (Fig.4). In contrast, no differences in fluorescence intensity were 
observed during hyperglycemia in dogs pretreated with tempol. 
Table 1. Systemic and coronary hemodynamics 
  Baseline Moderate 
Hyperglycemia 
Severe 
Hyperglycemia 
HR, beats/min 
   
 Vehicle 126 ± 7 120 ± 9 129 ± 11 
 Tempol 117 ± 4 99 ± 5* 103 ± 3*,† 
MBP, mmHg 
   
 Vehicle 100 ± 5 105 ± 5 107 ± 4 
 Tempol 92 ± 4 80 ± 4*,† 84 ± 2*,† 
LVSP, mmHg 
   
 Vehicle 115 ± 5 118 ± 5 122 ± 5 
 Tempol 103 ± 4 91 ± 3*,† 95 ± 2*,† 
LVEDP, mmHg 
   
 Vehicle 8 ± 1 9 ± 1 8 ± 1 
 Tempol 8 ± 1 8 ± 2 8 ± 2 
dP/dtmax, mmHg/s 
   
 Vehicle 1,640 ± 100 1,690 ± 110 1,910 ± 170* 
 Tempol 1,530 ± 130 1,590 ± 130 1,780 ± 190 
CBF, ml/min 
   
 Vehicle 40 ± 3 36 ± 4 41 ± 6 
 Tempol 37 ± 4 38 ± 3 40 ± 5 
LAD diameter, mm 
   
 Vehicle 2.5 ± 0.2 2.6 ± 0.2 2.6 ± 0.2 
 Tempol 2.1 ± 0.1 2.1 ± 0.1† 2.1 ± 0.1 
Blood glucose 
concentration, mg/dl 
   
 Vehicle 69 ± 4 346 ± 22* 581 ± 13* 
 Tempol 89 ± 5† 355 ± 31* 573 ± 6* 
Data are means ± SE. Vehicle, 0.9% saline; tempol, 4-hydroxy-2,2,6,6-tetrametylpiperidine 1-oxyl; HR, heart rate; 
MBP, mean arterial blood pressure; LVSP and LVEDP, left ventricular (LV) systolic and end-diastolic pressures, 
respectively; dP/dtmax, maximal rate of increase of LV pressure; CBF, coronary blood flow; LAD, left anterior 
descending coronary artery. 
*Significantly (P < 0.05) different from baseline; 
†significantly (P < 0.05) different from the respective value in the vehicle group. 
 
 
Fig. 3.Percent increase in LAD blood flow in response to left atrial administration of 10 (A), 30 (B), and 100 (C) 
ng/kg acetylcholine under control conditions and during hyperglycemia in dogs receiving vehicle and tempol. * 
Significantly (P < 0.05) different from baseline. 
 
 
Fig. 4.Representative photomicrographs illustrate the ethidium-DNA fluorescence in nuclei of cardiac myocytes 
as an index of production of reactive oxygen species under control conditions and during hyperglycemia in 
vehicle- and tempol-pretreated dogs. Histograms depict fluorescence intensity before and during hyperglycemia 
in dogs receiving vehicle and tempol. * Significantly (P < 0.05) different from baseline; †significantly (P < 0.05) 
different from the respective value in tempol-pretreated dogs; §significantly (P < 0.05) different from moderate 
hyperglycemia. 
 
No differences in blood viscosity were observed during administration of d-glucose at each shear rate in dogs 
pretreated with vehicle or tempol (Table 2). Pretreatment with tempol decreased blood viscosity compared with 
that in dogs receiving vehicle at shear rates ≤75 s−1 under baseline conditions. Blood viscosity was also 
consistently lower in dogs receiving tempol compared with vehicle during hyperglycemia. 
Table 2. Blood viscosity 
Shear Rate Baseline Moderate Hyperglycemia Severe Hyperglycemia 
375 s−1 
   
 Vehicle 3.47 ± 0.28 3.45 ± 0.15 3.42 ± 0.08 
 Tempol 3.01 ± 0.11 2.91 ± 0.13† 2.88 ± 0.14† 
187.5 s−1 
   
 Vehicle 3.86 ± 0.26 3.81 ± 0.16 3.87 ± 0.08 
 Tempol 3.23 ± 0.11 3.16 ± 0.15† 3.11 ± 0.16† 
75 s−1 
   
 Vehicle 4.45 ± 0.28 4.40 ± 0.19 4.32 ± 0.10 
 Tempol 3.60 ± 0.11† 3.37 ± 0.14† 3.40 ± 0.17† 
56.25 s−1 
   
 Vehicle 4.85 ± 0.35 4.77 ± 0.24 4.60 ± 0.15 
 Tempol 3.83 ± 0.12† 3.65 ± 0.14† 3.57 ± 0.19*,† 
30 s−1 
   
 Vehicle 5.71 ± 0.40 5.53 ± 0.31 5.14 ± 0.15 
 Tempol 4.36 ± 0.17† 4.26 ± 0.21† 4.11 ± 0.16† 
Data are means ± SE. Vehicle, 0.9% saline. 
*Significantly (P < 0.05) different from baseline; 
†significantly (P < 0.05) different from the respective value in the vehicle group. 
 
Global and myocardial wall shear stress were similar between vehicle- and tempol-pretreated groups under 
baseline conditions and during hyperglycemia (Table 3). Pericardial wall shear stress was significantly reduced in 
dogs pretreated with tempol compared with those receiving vehicle during severe hyperglycemia. 
Hyperglycemia decreased global and myocardial oscillatory shear stress in dogs receiving vehicle but not tempol 
(Fig.5). In contrast, oscillatory wall shear stress at the pericardial wall was unchanged during hyperglycemia. 
Hyperglycemia reduced the rate of global oscillatory shear stress in dogs receiving vehicle but not tempol (Fig.6). 
Reductions in the rate of shear stress oscillation were also observed at the myocardial luminal surface during 
moderate and severe hyperglycemia in dogs pretreated with vehicle and during severe hyperglycemia in dogs 
pretreated with tempol. No differences were observed in the rate of oscillatory wall shear stress at the 
pericardial luminal surface within and between groups. 
Table 3. Global and local wall shear stress 
  Baseline Moderate Hyperglycemia Severe Hyperglycemia 
Global shear stress 
   
 Vehicle 9.4 ± 1.5 8.2 ± 1.4 8.6 ± 1.5 
 Tempol 11.3 ± 2.6 8.4 ± 1.5 9.7 ± 1.2 
Myocardial wall shear stress 
   
 Vehicle 8.2 ± 1.2 6.8 ± 0.6 7.4 ± 1.4 
 Tempol 6.6 ± 1.5 8.3 ± 1.4 6.7 ± 1.1 
Pericardial wall shear stress 
   
 Vehicle 8.3 ± 1.7 9.7 ± 1.2 11.2 ± 1.0 
 Tempol 7.3 ± 0.4 8.3 ± 0.6 6.8 ± 0.83-150 
Data (in dyn/cm2) are means ± SE. Vehicle, 0.9% saline. 
F3-150Significantly (P < 0.05) different from the respective value in the vehicle group. 
 
 
Fig. 5.Alterations in global (A) and local wall shear stress at the myocardial (B) and pericardial (C) luminal 
surfaces at baseline and during hyperglycemia and in the absence (vehicle) or presence of tempol. * Significantly 
(P < 0.05) different from baseline; †significantly (P < 0.05) different from the respective value in dogs pretreated 
with tempol. 
 
 
 
Fig. 6.Alterations in the rate of oscillatory global (A), myocardial (B), and pericardial (C) wall shear stress under 
baseline conditions and during hyperglycemia in the absence (vehicle) or presence of tempol. * Significantly (P < 
0.05) different from baseline. 
 
DISCUSSION 
Endothelial dysfunction and increased production of ROS have been implicated in the pathogenesis of 
cardiovascular disease in patients with diabetes mellitus. Previous investigations demonstrated that the 
coronary endothelial dysfunction that occurs during hyperglycemia may be partially reversed by scavengers of 
oxygen-derived reactive intermediates (2, 21, 27, 30). The current results support these previous findings and 
further suggest that production of ROS during hyperglycemia contributes to reductions in oscillatory global and 
local wall shear stress in vivo. The results also demonstrate that the free radical scavenger tempol reverses 
hyperglycemic-induced decreases in oscillatory wall shear stress, indicating that ROS are responsible for these 
abnormalities in coronary fluid dynamics. The findings indicate that oscillatory but not mean wall shear stress 
was reduced during acute hyperglycemia. In contrast, decreases in mean wall shear stress were observed 
previously in arterial vessels obtained from patients with or experimental models of diabetes (15, 23). Whether 
these differences in indexes of wall shear stress observed during acute compared with chronic hyperglycemia 
represent a temporal adaptation to prolonged ROS generation remains to be evaluated. 
Oscillatory shear stresses measured at the myocardial and pericardial luminal surfaces of the coronary artery 
were differentially altered by hyperglycemia in the current investigation (Fig. 5). Previous fluid dynamic studies 
in the LAD and left main coronary artery showed that blood flow velocity profiles are skewed toward the 
pericardial surface, causing the velocity profile at the myocardial surface to become less steep and resulting in 
lower wall shear stress at the myocardial surface compared with the pericardial surface (Fig. 1B; Refs. 9, 23). A 
greater degree of flow reversal also occurs at the myocardial compared with the pericardial surface (22). This 
effect preferentially establishes lower oscillatory wall shear stress with a greater deviation of the principal wall 
shear stress vector from the dominant flow direction at the myocardial wall. These differences in wall shear 
stress profiles between myocardial and pericardial surfaces have been postulated to be responsible for the 
preferential location of atherosclerotic plaque formation at the myocardial wall in arteries obtained from 
patients with coronary or vascular occlusive disease (8, 9, 23). In contrast to low oscillatory shear stress states, 
increases in mean shear stress may have antiatherogenic effects by increasing superoxide dismutase (7) and NO 
synthase expression (40) and by increasing production of vasodilator prostanoids (33). Localized decreases in 
oscillatory wall stress at the myocardial wall observed during acute hyperglycemia in the current investigation 
may contribute to accelerated atherosclerosis during chronic hyperglycemia. This contention is supported by 
recent findings that endothelial dysfunction and increased vascular oxidative stress predict coronary artery 
disease in humans (10, 25). ROS production and subsequent changes in oscillatory shear stress may be a link 
between diabetes-induced hyperglycemia and progression of vascular disease. This intriguing hypothesis will 
require further investigation to confirm, however. 
Hyperglycemia is well known to produce endothelial dysfunction in coronary arteries dependent or independent 
of diabetes (20,27). The ability of tempol to restore endothelial function during hyperglycemia observed in the 
current investigation supports the results of a previous study in which a superoxide dismutase mimetic 
enhanced the vasodilator responsiveness of isolated aortic rings harvested from diabetic rats (30). Thus the 
current and previous studies strongly implicate a role for ROS in endothelial dysfunction during acute and 
chronic hyperglycemia. The present results further imply that hyperglycemia-induced endothelial dysfunction 
may precipitate flow conditions implicated in atherogenesis. Tempol reversed both the endothelial dysfunction 
(Fig. 3) and the decreases in oscillatory wall shear stress (Fig. 5) observed during hyperglycemia. These results 
suggest that indexes of wall shear stress may be useful as indirect indicators of oxidative stress in regions of 
arterial vasculature that may be susceptible to subsequent atherosclerosis. 
The results of the current investigation should be interpreted within the constraints of several potential 
limitations. Heart rate and mean arterial pressure were lower in dogs treated with tempol than in those 
receiving saline during hyperglycemia. These hemodynamic effects have been previously reported with tempol 
(39). The decreases in heart rate may account for the reduction in the rate of oscillatory shear stress observed 
during the target blood glucose concentration of 600 mg/dl in tempol-pretreated dogs. However, the rates of 
global and myocardial surface oscillatory shear stress were lower in dogs receiving vehicle than in those 
pretreated with tempol during hyperglycemia (Fig. 6). These data suggest that differences in the frequency of 
wall shear stress oscillations exerted on the endothelium between groups were not solely attributed to 
differences in heart rate. 
Blood viscosity was significantly reduced during the 600 mg/dl blood glucose concentration at a shear rate of 56 
s−1 in dogs pretreated with tempol. This reduction in blood viscosity is probably not physiologically relevant 
because the minimum shear rate determined from average regional blood flow velocity and internal LAD 
diameter for this experimental group was 67 s−1 (data not shown). Nevertheless, equations describing the 
relationship of blood viscosity and shear rate below 67 s−1 were required to evaluate the dynamic behavior of 
blood viscosity and shear stress for temporally varying shear rates. Blood viscosities at several shear rates were 
also significantly lower in the tempol- compared with vehicle-pretreated dogs. However, reductions in global 
and myocardial oscillatory wall shear stress during hyperglycemia in dogs pretreated with vehicle were greater 
than those observed in tempol-treated dogs. Thus alterations in wall shear stress were probably dependent on 
shear rate and not blood viscosity. These results also strongly suggest that the wall shear stress data presented 
here may actually underestimate changes produced by hyperglycemia. 
Intravenous administration of d-glucose may have caused hyperinsulinemia in the normal dogs used for the 
present investigation. However, we previously demonstrated (18) that many of the effects of hyperglycemia on 
ischemic myocardium occur independently of plasma insulin concentration. Coronary microvascular responses 
to graded coronary artery occlusion are similar in hyperglycemic (hyperinsulinemic) and diabetic (insulinopenic) 
dogs (17). l-Arginine restores coronary collateral blood flow during hyperglycemia without altering plasma 
insulin concentrations (19). Thus our previous findings suggest that hyperinsulinemia is unlikely to account for 
the deleterious effects of hyperglycemia observed in the current or previous investigations. The presence of 
hyperinsulinemia may actually underestimate the impact of hyperglycemia on the coronary circulation because 
recent evidence indicates that insulin increases myocardial blood flow in normoglycemic patients (14). 
The estimation of localized wall shear stress in arterial vessels with pulsed Doppler techniques may be prone to 
error for a Reynolds number typical of the blood flow through the coronary arteries (26). These errors in 
measurement may be attributed to the method of acquiring near-wall fluid velocity. The most precise technique 
assumes a fixed point on the vessel wall and then uses measured velocity points to calculate wall shear stress by 
least-squares interpolation. This method was implemented in the current investigation. In addition, the identical 
pulsed Doppler probe with a fixed insonation angle was used in each dog to minimize error. Local wall shear 
stress values reported previously for the LAD bifurcation (range of 5 to 33 dyn/cm2; Ref. 37) were also very 
similar to those obtained for myocardial and pericardial luminal surfaces of the LAD under control conditions in 
the current investigation (range of 5 to 29 dyn/cm2). 
Measurement of ROS was conducted in the cardiac myocyte and not the endothelium. Recent evidence suggests 
that an important source of hyperglycemia-induced ROS is the mitochondrial electron transport chain within the 
cardiac myocyte (32). Thus determination of fluorescence intensities in myocardial nuclei identifies a likely 
source of ROS production that may subsequently affect coronary endothelial function. However, additional 
studies will be required to verify this hypothesis. Production of ROS may actually be underestimated by the 
dihydroethidium technique during hyperglycemia because the amount of dihydroethidium oxidized to ethidium 
may decrease as the rate of ROS generation increases (3). Such a situation could have occurred during severe 
hyperglycemia in the current investigation. Nevertheless, although measurements of ROS production may have 
underestimated the amount of ROS generated during hyperglycemia, the dose of tempol used in the present 
investigation was probably adequate to scavenge these reactive intermediates because nuclei fluorescence and 
endothelial function were unchanged after administration of intravenous hyperglycemia in dogs pretreated with 
tempol. As such, fluorescent intensity and endothelial function were unaffected by hyperglycemia for dogs in 
the tempol-treated group. 
In summary, the present results indicate that acute hyperglycemia increases ROS production in vivo. These 
reactive intermediates cause endothelial dysfunction and reduce both global and local oscillatory wall shear 
stress in intact coronary arteries. Whether the influence of acute hyperglycemia on ROS-dependent decreases in 
wall shear stress and endothelial function is linked to a subsequent increase in cardiovascular risk during 
diabetes remains to be established. 
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